Description
Walrycin B inhibits the walrycin response regulator (WalR). This compound exhibits antibacterial activity, altering cell wall metabolism and cell division in Bacillus and Staphylococcus.
Product Unit Size | Cost | Quantity | Stock |
---|
Walrycin B inhibits the walrycin response regulator (WalR). This compound exhibits antibacterial activity, altering cell wall metabolism and cell division in Bacillus and Staphylococcus.
Cas No. | 878419-78-4 |
---|---|
Purity | ≥98% |
Formula | C14H10F3N5O2 |
Formula Wt. | 337.26 |
IUPAC Name | 1,6-Dimethyl-3-[4-(trifluoromethyl)phenyl]pyrimido[5,4-e][1,2,4]triazine-5,7(1H,6H)-dione |
Solubility | DMSO: 11.5 mg/mL |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Gotoh Y, Doi A, Furuta E, et al. Novel antibacterial compounds specifically targeting the essential WalR response regulator. J Antibiot (Tokyo). 2010 Mar;63(3):127-34. PMID: 20111065.
TRPC5, NS4B, histamine H1 inhibitor.
NSAID; COX-1/2 inhibitor.
PAI-1 inhibitor.
Pheniramine derivative; histamine H1 and mAChR ...
Coccidiostat.
B-Raf and c-Raf inhibitor.
Endogenous pteridine metabolite of GTP.
Phenylpyrazoleanilide; IL-17 production inhibit...
ROCK1/2 inhibitor, potential RSK and p70S6K inh...
Nucleoside (deoxyguanosine) analog; DNA chain t...
Cholesterol ester transfer protein inhibitor.
Diterpene found in Taxus; potential microtubule...
Polyketide; CRM1 inhibitor.
Endogenous peptide, involved in vascular contra...
Tetracycline; protein translation inhibitor, MM...
Viral RNA polymerase inhibitor.
PKA inhibitor, potential ROCK, S6K1, MSK1, PKB ...
Selective HDAC4 and HDAC5 inhibitor.
GSK3 and AChE inhibitor, potential σ1 agonist....
BHA derivative.